Immediate Impact

3 from Science/Nature 57 standout
Sub-graph 1 of 23

Citing Papers

Pancreatic cancer
2025 Standout
The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy
2025 Standout
1 intermediate paper

Works of James M. Pauff being referenced

P636: A FIRST-IN-HUMAN PHASE 1 STUDY OF ORAL LOXO-338, A SELECTIVE BCL2 INHIBITOR, IN PATIENTS WITH ADVANCED HEMATOLOGIC MALIGNANCIES
2023
P683: A FIRST-IN-HUMAN PHASE 1 STUDY OF ORAL LOXO-338, A SELECTIVE BCL2 INHIBITOR, IN PATIENTS WITH ADVANCED HEMATOLOGIC MALIGNANCIES (TRIAL IN PROGRESS)
2022
and 1 more

Author Peers

Author Last Decade Papers Cites
James M. Pauff 388 98 141 239 23 815
Nan Lin 430 25 83 84 24 905
Fung Lau 277 50 76 28 33 985
Jan Goeman 341 16 39 283 30 936
Antje Havemeyer 326 21 181 32 26 866
Elena Martínez‐Klimova 279 14 24 150 28 845
Donald Moss 397 21 207 52 36 753
Xiaoqian Yang 176 9 64 35 50 825
Mei Han 393 5 385 131 30 935
Thomas Pfeifer 230 6 62 28 33 703
Khe-Ni Ma 227 28 321 47 16 923

All Works

Loading papers...

Rankless by CCL
2026